Hofheinz RD - Search Results

1

Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer.

Boda-Heggemann J, Hofheinz RD, Weiss C, Mennemeyer P, Mai SK, Hermes P, Wertz H, Post S, Massner B, Hieber U, Hochhaus A, Wenz F, Lohr F. Boda-Heggemann J, et al. Among authors: hofheinz rd. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1187-95. doi: 10.1016/j.ijrobp.2008.12.036. Epub 2009 May 4. Int J Radiat Oncol Biol Phys. 2009. PMID: 19409725

2

Neoadjuvant radio-chemotherapy of adenocarcinoma of the oesophagogastric junction.

Samel S, Hofheinz R, Hundt A, Sturm J, Knoll MR, Wenz F, Queisser W, Post S. Samel S, et al. Onkologie. 2001 Jun;24(3):278-82. doi: 10.1159/000055092. Onkologie. 2001. PMID: 11455222 English, German.

3

Malignant intestinal non-Hodgkin's lymphoma from the surgical point of view.

Samel S, Wagner J, Hofheinz R, Sturm J, Post S. Samel S, et al. Onkologie. 2002 Jun;25(3):268-71. doi: 10.1159/000064321. Onkologie. 2002. PMID: 12119462

4

Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patient.

Hofheinz RD, Nguyen XD, Buchheidt D, Kerowgan M, Hehlmann R, Hochhaus A. Hofheinz RD, et al. Cancer Chemother Pharmacol. 2004 Mar;53(3):276-7. doi: 10.1007/s00280-003-0731-8. Epub 2003 Dec 16. Cancer Chemother Pharmacol. 2004. PMID: 14676977

5

Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study.

Hofheinz RD, Gnad-Vogt U, Wein A, Saussele S, Kreil S, Pilz L, Hehlmann R, Hochhaus A. Hofheinz RD, et al. Anticancer Drugs. 2005 Jan;16(1):39-45. doi: 10.1097/00001813-200501000-00005. Anticancer Drugs. 2005. PMID: 15613902 Clinical Trial.

6

Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer.

Hofheinz RD, von Gerstenberg-Helldorf B, Wenz F, Gnad U, Kraus-Tiefenbacher U, Müldner A, Hehlmann R, Post S, Hochhaus A, Willeke F. Hofheinz RD, et al. J Clin Oncol. 2005 Mar 1;23(7):1350-7. doi: 10.1200/JCO.2005.04.171. Epub 2005 Jan 31. J Clin Oncol. 2005. PMID: 15684318 Clinical Trial.

7

Pegylated liposomal doxorubicin and mitomycin C in combination with infusional 5-fluorouracil and sodium folinic acid in the treatment of advanced gastric cancer: results of a phase II trial.

Gnad-Vogt SU, Hofheinz RD, Saussele S, Kreil S, Willer A, Willeke F, Pilz L, Hehlmann R, Hochhaus A. Gnad-Vogt SU, et al. Among authors: hofheinz rd. Anticancer Drugs. 2005 Apr;16(4):435-40. doi: 10.1097/00001813-200504000-00010. Anticancer Drugs. 2005. PMID: 15746580 Clinical Trial.

8

Infusional 5-fluorouracil and mitomycin C: an effective regimen in the treatment of advanced gastric cancer.

Rudi J, Werle S, Bergtholdt D, Hofheinz RD. Rudi J, et al. Among authors: hofheinz rd. Onkologie. 2005 Mar;28(3):128-32. doi: 10.1159/000083244. Onkologie. 2005. PMID: 15772462 Clinical Trial.

9

Liposomal encapsulated anti-cancer drugs.

Hofheinz RD, Gnad-Vogt SU, Beyer U, Hochhaus A. Hofheinz RD, et al. Anticancer Drugs. 2005 Aug;16(7):691-707. doi: 10.1097/01.cad.0000167902.53039.5a. Anticancer Drugs. 2005. PMID: 16027517 Review.

10

Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer.

Staiger WI, Coy JF, Grobholz R, Hofheinz RD, Lukan N, Post S, Schwarzbach MH, Willeke F. Staiger WI, et al. Among authors: hofheinz rd. Oncol Rep. 2006 Oct;16(4):657-61. Oncol Rep. 2006. PMID: 16969476

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters